The global market for Injectable Microspheres was valued at US$ 196 million in the year 2024 and is projected to reach a revised size of US$ 288 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Injectable microspheres are tiny, biocompatible, and biodegradable spherical particles used for controlled drug delivery, aesthetic medicine, and regenerative therapies. Microspheres are commonly used as depot drug carriers for long-acting delivery and usually administered intramuscularly or subcutaneously. A depot delivery system requires particle sizes above 5 渭m in order to remain at the injection site and slowly release drug contents.
North American market for Injectable Microspheres is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Injectable Microspheres is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Injectable Microspheres include Novartis, Ferring, Ipsen, Takeda, Roche, AstraZeneca, OraPharma, Alkermes, Pacira BioSciences, Xian Janssen Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injectable Microspheres, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Microspheres.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Injectable Microspheres competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Injectable Microspheres market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Microspheres market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Microspheres manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
Ferring
Ipsen
Takeda
Roche
AstraZeneca
OraPharma
Alkermes
Pacira BioSciences
Xian Janssen Pharmaceutical
Shandong Luye Pharmaceutical
Livzon Pharmaceutical
Zhejiang Sundoc Pharmaceutical Science and Tech
Beijing Boente Pharmaceutical
Guangzhou DiQi Pharmaceuticals
Qilu Pharmaceutical
Changchun GeneScience Pharmaceutical
Anhui BBCA Biochemical
Yichang Humanwell Pharmaceutical
Segment by Type
Risperidone Microspheres
Leuprorelin Microspheres
Octreotide Microspheres
Triptorelin Microspheres
Others
Segment by Application
Malignant Tumors
Diabetes
Cardiovascular Diseases
Mental Illness
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Microspheres in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Injectable Microspheres Market Overview
1.1 Product Definition
1.2 Injectable Microspheres by Type
1.2.1 Global Injectable Microspheres Market Value Comparison by Type (2024 VS 2031)
1.2.2 Risperidone Microspheres
1.2.3 Leuprorelin Microspheres
1.2.4 Octreotide Microspheres
1.2.5 Triptorelin Microspheres
1.2.6 Others
1.3 Injectable Microspheres by Application
1.3.1 Global Injectable Microspheres Market Value by Application (2024 VS 2031)
1.3.2 Malignant Tumors
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Mental Illness
1.3.6 Others
1.4 Global Injectable Microspheres Market Size Estimates and Forecasts
1.4.1 Global Injectable Microspheres Revenue 2020-2031
1.4.2 Global Injectable Microspheres Sales 2020-2031
1.4.3 Global Injectable Microspheres Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Injectable Microspheres Market Competition by Manufacturers
2.1 Global Injectable Microspheres Sales Market Share by Manufacturers (2020-2025)
2.2 Global Injectable Microspheres Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Injectable Microspheres Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Injectable Microspheres, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Microspheres, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Microspheres, Product Type & Application
2.7 Global Key Manufacturers of Injectable Microspheres, Date of Enter into This Industry
2.8 Global Injectable Microspheres Market Competitive Situation and Trends
2.8.1 Global Injectable Microspheres Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Injectable Microspheres Players Market Share by Revenue
2.8.3 Global Injectable Microspheres Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injectable Microspheres Market Scenario by Region
3.1 Global Injectable Microspheres Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Injectable Microspheres Sales by Region: 2020-2031
3.2.1 Global Injectable Microspheres Sales by Region: 2020-2025
3.2.2 Global Injectable Microspheres Sales by Region: 2026-2031
3.3 Global Injectable Microspheres Revenue by Region: 2020-2031
3.3.1 Global Injectable Microspheres Revenue by Region: 2020-2025
3.3.2 Global Injectable Microspheres Revenue by Region: 2026-2031
3.4 North America Injectable Microspheres Market Facts & Figures by Country
3.4.1 North America Injectable Microspheres Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Injectable Microspheres Sales by Country (2020-2031)
3.4.3 North America Injectable Microspheres Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Microspheres Market Facts & Figures by Country
3.5.1 Europe Injectable Microspheres Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Injectable Microspheres Sales by Country (2020-2031)
3.5.3 Europe Injectable Microspheres Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Microspheres Market Facts & Figures by Region
3.6.1 Asia Pacific Injectable Microspheres Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Injectable Microspheres Sales by Region (2020-2031)
3.6.3 Asia Pacific Injectable Microspheres Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injectable Microspheres Market Facts & Figures by Country
3.7.1 Latin America Injectable Microspheres Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Injectable Microspheres Sales by Country (2020-2031)
3.7.3 Latin America Injectable Microspheres Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injectable Microspheres Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Microspheres Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Injectable Microspheres Sales by Country (2020-2031)
3.8.3 Middle East and Africa Injectable Microspheres Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Microspheres Sales by Type (2020-2031)
4.1.1 Global Injectable Microspheres Sales by Type (2020-2025)
4.1.2 Global Injectable Microspheres Sales by Type (2026-2031)
4.1.3 Global Injectable Microspheres Sales Market Share by Type (2020-2031)
4.2 Global Injectable Microspheres Revenue by Type (2020-2031)
4.2.1 Global Injectable Microspheres Revenue by Type (2020-2025)
4.2.2 Global Injectable Microspheres Revenue by Type (2026-2031)
4.2.3 Global Injectable Microspheres Revenue Market Share by Type (2020-2031)
4.3 Global Injectable Microspheres Price by Type (2020-2031)
5 Segment by Application
5.1 Global Injectable Microspheres Sales by Application (2020-2031)
5.1.1 Global Injectable Microspheres Sales by Application (2020-2025)
5.1.2 Global Injectable Microspheres Sales by Application (2026-2031)
5.1.3 Global Injectable Microspheres Sales Market Share by Application (2020-2031)
5.2 Global Injectable Microspheres Revenue by Application (2020-2031)
5.2.1 Global Injectable Microspheres Revenue by Application (2020-2025)
5.2.2 Global Injectable Microspheres Revenue by Application (2026-2031)
5.2.3 Global Injectable Microspheres Revenue Market Share by Application (2020-2031)
5.3 Global Injectable Microspheres Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Injectable Microspheres Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Ferring
6.2.1 Ferring Company Information
6.2.2 Ferring Description and Business Overview
6.2.3 Ferring Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ferring Injectable Microspheres Product Portfolio
6.2.5 Ferring Recent Developments/Updates
6.3 Ipsen
6.3.1 Ipsen Company Information
6.3.2 Ipsen Description and Business Overview
6.3.3 Ipsen Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ipsen Injectable Microspheres Product Portfolio
6.3.5 Ipsen Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Company Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Injectable Microspheres Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 Roche
6.5.1 Roche Company Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Roche Injectable Microspheres Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Injectable Microspheres Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 OraPharma
6.7.1 OraPharma Company Information
6.7.2 OraPharma Description and Business Overview
6.7.3 OraPharma Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OraPharma Injectable Microspheres Product Portfolio
6.7.5 OraPharma Recent Developments/Updates
6.8 Alkermes
6.8.1 Alkermes Company Information
6.8.2 Alkermes Description and Business Overview
6.8.3 Alkermes Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Alkermes Injectable Microspheres Product Portfolio
6.8.5 Alkermes Recent Developments/Updates
6.9 Pacira BioSciences
6.9.1 Pacira BioSciences Company Information
6.9.2 Pacira BioSciences Description and Business Overview
6.9.3 Pacira BioSciences Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pacira BioSciences Injectable Microspheres Product Portfolio
6.9.5 Pacira BioSciences Recent Developments/Updates
6.10 Xian Janssen Pharmaceutical
6.10.1 Xian Janssen Pharmaceutical Company Information
6.10.2 Xian Janssen Pharmaceutical Description and Business Overview
6.10.3 Xian Janssen Pharmaceutical Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Xian Janssen Pharmaceutical Injectable Microspheres Product Portfolio
6.10.5 Xian Janssen Pharmaceutical Recent Developments/Updates
6.11 Shandong Luye Pharmaceutical
6.11.1 Shandong Luye Pharmaceutical Company Information
6.11.2 Shandong Luye Pharmaceutical Description and Business Overview
6.11.3 Shandong Luye Pharmaceutical Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shandong Luye Pharmaceutical Injectable Microspheres Product Portfolio
6.11.5 Shandong Luye Pharmaceutical Recent Developments/Updates
6.12 Livzon Pharmaceutical
6.12.1 Livzon Pharmaceutical Company Information
6.12.2 Livzon Pharmaceutical Description and Business Overview
6.12.3 Livzon Pharmaceutical Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Livzon Pharmaceutical Injectable Microspheres Product Portfolio
6.12.5 Livzon Pharmaceutical Recent Developments/Updates
6.13 Zhejiang Sundoc Pharmaceutical Science and Tech
6.13.1 Zhejiang Sundoc Pharmaceutical Science and Tech Company Information
6.13.2 Zhejiang Sundoc Pharmaceutical Science and Tech Description and Business Overview
6.13.3 Zhejiang Sundoc Pharmaceutical Science and Tech Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Zhejiang Sundoc Pharmaceutical Science and Tech Injectable Microspheres Product Portfolio
6.13.5 Zhejiang Sundoc Pharmaceutical Science and Tech Recent Developments/Updates
6.14 Beijing Boente Pharmaceutical
6.14.1 Beijing Boente Pharmaceutical Company Information
6.14.2 Beijing Boente Pharmaceutical Description and Business Overview
6.14.3 Beijing Boente Pharmaceutical Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Beijing Boente Pharmaceutical Injectable Microspheres Product Portfolio
6.14.5 Beijing Boente Pharmaceutical Recent Developments/Updates
6.15 Guangzhou DiQi Pharmaceuticals
6.15.1 Guangzhou DiQi Pharmaceuticals Company Information
6.15.2 Guangzhou DiQi Pharmaceuticals Description and Business Overview
6.15.3 Guangzhou DiQi Pharmaceuticals Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Guangzhou DiQi Pharmaceuticals Injectable Microspheres Product Portfolio
6.15.5 Guangzhou DiQi Pharmaceuticals Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Company Information
6.16.2 Qilu Pharmaceutical Description and Business Overview
6.16.3 Qilu Pharmaceutical Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Qilu Pharmaceutical Injectable Microspheres Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Changchun GeneScience Pharmaceutical
6.17.1 Changchun GeneScience Pharmaceutical Company Information
6.17.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.17.3 Changchun GeneScience Pharmaceutical Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Changchun GeneScience Pharmaceutical Injectable Microspheres Product Portfolio
6.17.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
6.18 Anhui BBCA Biochemical
6.18.1 Anhui BBCA Biochemical Company Information
6.18.2 Anhui BBCA Biochemical Description and Business Overview
6.18.3 Anhui BBCA Biochemical Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Anhui BBCA Biochemical Injectable Microspheres Product Portfolio
6.18.5 Anhui BBCA Biochemical Recent Developments/Updates
6.19 Yichang Humanwell Pharmaceutical
6.19.1 Yichang Humanwell Pharmaceutical Company Information
6.19.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.19.3 Yichang Humanwell Pharmaceutical Injectable Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Yichang Humanwell Pharmaceutical Injectable Microspheres Product Portfolio
6.19.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Microspheres Industry Chain Analysis
7.2 Injectable Microspheres Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Microspheres Production Mode & Process Analysis
7.4 Injectable Microspheres Sales and Marketing
7.4.1 Injectable Microspheres Sales Channels
7.4.2 Injectable Microspheres Distributors
7.5 Injectable Microspheres Customer Analysis
8 Injectable Microspheres Market Dynamics
8.1 Injectable Microspheres Industry Trends
8.2 Injectable Microspheres Market Drivers
8.3 Injectable Microspheres Market Challenges
8.4 Injectable Microspheres Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Novartis
Ferring
Ipsen
Takeda
Roche
AstraZeneca
OraPharma
Alkermes
Pacira BioSciences
Xian Janssen Pharmaceutical
Shandong Luye Pharmaceutical
Livzon Pharmaceutical
Zhejiang Sundoc Pharmaceutical Science and Tech
Beijing Boente Pharmaceutical
Guangzhou DiQi Pharmaceuticals
Qilu Pharmaceutical
Changchun GeneScience Pharmaceutical
Anhui BBCA Biochemical
Yichang Humanwell Pharmaceutical
听
听
*If Applicable.
